These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25590813)

  • 1. Structure-activity relationship for the oxadiazole class of antibiotics.
    Spink E; Ding D; Peng Z; Boudreau MA; Leemans E; Lastochkin E; Song W; Lichtenwalter K; O'Daniel PI; Testero SA; Pi H; Schroeder VA; Wolter WR; Antunes NT; Suckow MA; Vakulenko S; Chang M; Mobashery S
    J Med Chem; 2015 Feb; 58(3):1380-9. PubMed ID: 25590813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibiotics.
    Ding D; Boudreau MA; Leemans E; Spink E; Yamaguchi T; Testero SA; O'Daniel PI; Lastochkin E; Chang M; Mobashery S
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4854-4857. PubMed ID: 26144346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA).
    Hannoun MH; Hagras M; Kotb A; El-Attar AMM; Abulkhair HS
    Bioorg Chem; 2020 Jan; 94():103364. PubMed ID: 31668461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).
    Guo Y; Xu T; Bao C; Liu Z; Fan J; Yang R; Qin S
    Eur J Pharm Sci; 2019 Aug; 136():104966. PubMed ID: 31233865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oxadiazole antibacterials.
    Janardhanan J; Chang M; Mobashery S
    Curr Opin Microbiol; 2016 Oct; 33():13-17. PubMed ID: 27239942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies.
    Verma SK; Verma R; Kumar KSS; Banjare L; Shaik AB; Bhandare RR; Rakesh KP; Rangappa KS
    Eur J Med Chem; 2021 Jul; 219():113442. PubMed ID: 33878562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
    Liu J; Zhang GY; Zhang Z; Li B; Chai F; Wang Q; Zhou ZD; Xu LL; Wang SK; Jin Z; Tang YZ
    Bioorg Chem; 2021 Jul; 112():104956. PubMed ID: 33991838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria.
    Ceballos S; Kim C; Ding D; Mobashery S; Chang M; Torres C
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.
    Wang J; Ansari MF; Zhou CH
    Bioorg Med Chem Lett; 2021 Jun; 41():127995. PubMed ID: 33775834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens.
    Fortuna CG; Bonaccorso C; Bulbarelli A; Caltabiano G; Rizzi L; Goracci L; Musumarra G; Pace A; Palumbo Piccionello A; Guarcello A; Pierro P; Cocuzza CE; Musumeci R
    Eur J Med Chem; 2013 Jul; 65():533-45. PubMed ID: 23811204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus.
    Zheng Z; Liu Q; Kim W; Tharmalingam N; Fuchs BB; Mylonakis E
    Future Med Chem; 2018 Feb; 10(3):283-296. PubMed ID: 29334249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II).
    Cheng C; Liu Y; Song H; Pan L; Li J; Qin Y; Li R
    Mar Drugs; 2013 Aug; 11(8):2927-48. PubMed ID: 23955285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles.
    Rai NP; Narayanaswamy VK; Shashikanth S; Arunachalam PN
    Eur J Med Chem; 2009 Nov; 44(11):4522-7. PubMed ID: 19640616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity.
    O'Daniel PI; Peng Z; Pi H; Testero SA; Ding D; Spink E; Leemans E; Boudreau MA; Yamaguchi T; Schroeder VA; Wolter WR; Llarrull LI; Song W; Lastochkin E; Kumarasiri M; Antunes NT; Espahbodi M; Lichtenwalter K; Suckow MA; Vakulenko S; Mobashery S; Chang M
    J Am Chem Soc; 2014 Mar; 136(9):3664-72. PubMed ID: 24517363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New potent antibacterials against Gram-positive multiresistant pathogens: effects of side chain modification and chirality in linezolid-like 1,2,4-oxadiazoles.
    Fortuna CG; Berardozzi R; Bonaccorso C; Caltabiano G; Di Bari L; Goracci L; Guarcello A; Pace A; Palumbo Piccionello A; Pescitelli G; Pierro P; Lonati E; Bulbarelli A; Cocuzza CE; Musumarra G; Musumeci R
    Bioorg Med Chem; 2014 Dec; 22(24):6814-25. PubMed ID: 25464880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.
    Leemans E; Mahasenan KV; Kumarasiri M; Spink E; Ding D; O'Daniel PI; Boudreau MA; Lastochkin E; Testero SA; Yamaguchi T; Lee M; Hesek D; Fisher JF; Chang M; Mobashery S
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1011-1015. PubMed ID: 26733473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives.
    Hoemann MZ; Kumaravel G; Xie RL; Rossi RF; Meyer S; Sidhu A; Cuny GD; Hauske JR
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2675-8. PubMed ID: 11128649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections.
    Wei H; Mao F; Ni S; Chen F; Li B; Qiu X; Hu L; Wang M; Zheng X; Zhu J; Lan L; Li J
    Eur J Med Chem; 2018 Feb; 145():235-251. PubMed ID: 29328999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel 1,2,5-oxadiazoles and evaluation of action against Acinetobacter baumannii.
    Christoff RM; Murray GL; Kostoulias XP; Peleg AY; Abbott BM
    Bioorg Med Chem; 2017 Dec; 25(24):6267-6272. PubMed ID: 29032931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives.
    Jha KK; Samad A; Kumar Y; Shaharyar M; Khosa RL; Jain J; Kumar V; Singh P
    Eur J Med Chem; 2010 Nov; 45(11):4963-7. PubMed ID: 20817328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.